Cargando…

405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19

BACKGROUND: The rate of bacterial and/or fungal infections among COVID-19 cases is reportedly low. Antimicrobial Stewardship Programs (ASPs) provide continuous surveillance of blood cultures to secure appropriate choice and duration of therapy. Comparing to historic data, we characterize our ASP exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Adam, Liappis, Angelike P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778292/
http://dx.doi.org/10.1093/ofid/ofaa439.600
_version_ 1783631101425614848
author Klein, Adam
Liappis, Angelike P
author_facet Klein, Adam
Liappis, Angelike P
author_sort Klein, Adam
collection PubMed
description BACKGROUND: The rate of bacterial and/or fungal infections among COVID-19 cases is reportedly low. Antimicrobial Stewardship Programs (ASPs) provide continuous surveillance of blood cultures to secure appropriate choice and duration of therapy. Comparing to historic data, we characterize our ASP experience in bacteremic surveillance during the COVID-19 pandemic. METHODS: Consecutive blood cultures at the Washington DC VA Medical Center were captured in an ASP-driven decision support software system (TheraDoc, Premier/DSS Inc) between Jan 1(st) 2018-May 31st 2020. In the setting of an established ASP, the organism positive cultures were reviewed over the first five months (Jan-May) of each of the three years collected. Results of cultures were characterized as either pathogenic gram positive (MSSA/MRSA/Enterococci/PSSP/PRSP/Strep sp.), pathogenic aerobic and anaerobic gram negative organisms and a skin contaminant-category (GPRs/skin flora/CNS). RESULTS: Over 3 yrs, 528 patients had 1464 positive cultures from among 8727 admissions, 83638 inpatient-days. The proportion of pathogenic GP bacteria and pathogenic GN bacteria were not statistically significantly different 38% (2018) vs 37% (2019) vs 39% (2020) and 33%, 31%, 27% respectively. There was slight trend in the increase of pathogenic GP 9.6 vs 9.5 vs 11.7 per 1,000 inpatient days and skin contaminant-category with 12.0 vs 11.0 vs. 14.1 per 1,000 patient days from 2019 to 2020. We noted a dramatic shift in culture surveillance report during the peak COVID-infection rates (March-April), notable for several weeks of few to no culture positive results. When broken down by month, variability was noted (data not shown). COVID-19 infected patients represented 9.0% (7/78) of positive blood culture results in 2020 Jan-May, only 5.1% (4/78) were treated as non-contaminants and were related to indwelling catheters or urosepsis. CONCLUSION: Overall and adjusted rates of the blood cultures sent during the pandemic months in 2020 were comparable to the comparative years. Surveillance revealed short term changes in patterns which may have reflected the pandemic induced changes to admissions. COVID-19 infected patients rarely experienced line and hospital acquired bactermia/fungemia, most during the recovery period. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7778292
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77782922021-01-07 405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19 Klein, Adam Liappis, Angelike P Open Forum Infect Dis Poster Abstracts BACKGROUND: The rate of bacterial and/or fungal infections among COVID-19 cases is reportedly low. Antimicrobial Stewardship Programs (ASPs) provide continuous surveillance of blood cultures to secure appropriate choice and duration of therapy. Comparing to historic data, we characterize our ASP experience in bacteremic surveillance during the COVID-19 pandemic. METHODS: Consecutive blood cultures at the Washington DC VA Medical Center were captured in an ASP-driven decision support software system (TheraDoc, Premier/DSS Inc) between Jan 1(st) 2018-May 31st 2020. In the setting of an established ASP, the organism positive cultures were reviewed over the first five months (Jan-May) of each of the three years collected. Results of cultures were characterized as either pathogenic gram positive (MSSA/MRSA/Enterococci/PSSP/PRSP/Strep sp.), pathogenic aerobic and anaerobic gram negative organisms and a skin contaminant-category (GPRs/skin flora/CNS). RESULTS: Over 3 yrs, 528 patients had 1464 positive cultures from among 8727 admissions, 83638 inpatient-days. The proportion of pathogenic GP bacteria and pathogenic GN bacteria were not statistically significantly different 38% (2018) vs 37% (2019) vs 39% (2020) and 33%, 31%, 27% respectively. There was slight trend in the increase of pathogenic GP 9.6 vs 9.5 vs 11.7 per 1,000 inpatient days and skin contaminant-category with 12.0 vs 11.0 vs. 14.1 per 1,000 patient days from 2019 to 2020. We noted a dramatic shift in culture surveillance report during the peak COVID-infection rates (March-April), notable for several weeks of few to no culture positive results. When broken down by month, variability was noted (data not shown). COVID-19 infected patients represented 9.0% (7/78) of positive blood culture results in 2020 Jan-May, only 5.1% (4/78) were treated as non-contaminants and were related to indwelling catheters or urosepsis. CONCLUSION: Overall and adjusted rates of the blood cultures sent during the pandemic months in 2020 were comparable to the comparative years. Surveillance revealed short term changes in patterns which may have reflected the pandemic induced changes to admissions. COVID-19 infected patients rarely experienced line and hospital acquired bactermia/fungemia, most during the recovery period. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7778292/ http://dx.doi.org/10.1093/ofid/ofaa439.600 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Klein, Adam
Liappis, Angelike P
405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19
title 405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19
title_full 405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19
title_fullStr 405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19
title_full_unstemmed 405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19
title_short 405. Trend in blood culture results in Washington DC during and prior to Pandemic COVID-19
title_sort 405. trend in blood culture results in washington dc during and prior to pandemic covid-19
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778292/
http://dx.doi.org/10.1093/ofid/ofaa439.600
work_keys_str_mv AT kleinadam 405trendinbloodcultureresultsinwashingtondcduringandpriortopandemiccovid19
AT liappisangelikep 405trendinbloodcultureresultsinwashingtondcduringandpriortopandemiccovid19